Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Paclitaxel: biosynthesis, production and future prospects.

Howat S, Park B, Oh IS, Jin YW, Lee EK, Loake GJ.

N Biotechnol. 2014 May 25;31(3):242-5. doi: 10.1016/j.nbt.2014.02.010. Epub 2014 Mar 11. Review.

PMID:
24614567
2.

4-Deacetylbaccatin III: a proposed biosynthetic precursor of paclitaxel from the bark of Taxus wallichiana.

Nisar M, Qayum M, Adhikari A, Khan I, Kaleem WA, Ali Z, Choudhary MI.

Nat Prod Commun. 2010 Nov;5(11):1727-8.

PMID:
21213967
3.
4.

[Recent advances in the biosynthesis of Taxol].

Kong JQ, Wang W, Zhu P, Cheng KD.

Yao Xue Xue Bao. 2007 Apr;42(4):358-65. Review. Chinese.

PMID:
17633200
5.

Development of Taxol and other endophyte produced anti-cancer agents.

Miller K, Neilan B, Sze DM.

Recent Pat Anticancer Drug Discov. 2008 Jan;3(1):14-9. Review.

PMID:
18289120
6.

Biotechnological production of taxol and related taxoids: current state and prospects.

Expósito O, Bonfill M, Moyano E, Onrubia M, Mirjalili MH, Cusidó RM, Palazón J.

Anticancer Agents Med Chem. 2009 Jan;9(1):109-21. Review.

PMID:
19149486
7.

[The advance in synthetic biology: towards a microbe-derived paclitaxel intermediates].

Wang W, Yang Y, Zheng XD, Huang SQ, Guo L, Kong JQ, Cheng KD.

Yao Xue Xue Bao. 2013 Feb;48(2):187-92. Review. Chinese.

PMID:
23672014
8.

The early stages of taxol biosynthesis: an interim report on the synthesis and identification of early pathway metabolites.

Guerra-Bubb J, Croteau R, Williams RM.

Nat Prod Rep. 2012 Jun;29(6):683-96. doi: 10.1039/c2np20021j. Epub 2012 May 1. Review.

9.

Paclitaxel: a new antimitotic chemotherapeutic agent.

Gotaskie GE, Andreassi BF.

Cancer Pract. 1994 Jan-Feb;2(1):27-33. Review.

PMID:
7914453
10.

Metabolic engineering approaches for production of biochemicals in food and medicinal plants.

Wilson SA, Roberts SC.

Curr Opin Biotechnol. 2014 Apr;26:174-82. doi: 10.1016/j.copbio.2014.01.006. Epub 2014 Feb 18. Review.

PMID:
24556196
11.

[Research progress and trend analysis of biology and chemistry of Taxus medicinal resources].

Hao DC, Xiao PG, Peng Y, Liu M, Huo L.

Yao Xue Xue Bao. 2012 Jul;47(7):827-35. Review. Chinese.

PMID:
22993844
12.

[Effects of fosmidomycin and lovastatin treatment on taxol biosynthesis in suspension culture cells of Taxus chinensis].

Liu Z, Yu LJ, Li CY, Zhao CF.

Zhi Wu Sheng Li Yu Fen Zi Sheng Wu Xue Xue Bao. 2005 Apr;31(2):199-204. Chinese.

PMID:
15840939
13.

Advancements in the understanding of Paclitaxel metabolism in tissue culture.

Vongpaseuth K, Roberts SC.

Curr Pharm Biotechnol. 2007 Aug;8(4):219-36. Review.

PMID:
17691991
14.

Paclitaxel production by plant-cell-culture technology.

Tabata H.

Adv Biochem Eng Biotechnol. 2004;87:1-23. Review.

PMID:
15217102
15.

Chemical inhibitors suggest endophytic fungal paclitaxel is derived from both mevalonate and non-mevalonate-like pathways.

Soliman SS, Tsao R, Raizada MN.

J Nat Prod. 2011 Dec 27;74(12):2497-504. doi: 10.1021/np200303v. Epub 2011 Nov 21.

PMID:
22103292
16.
17.

Taxol: biosynthesis, molecular genetics, and biotechnological applications.

Jennewein S, Croteau R.

Appl Microbiol Biotechnol. 2001 Oct;57(1-2):13-9. Review.

PMID:
11693909
18.

Taxol biosynthesis: an update.

Hezari M, Croteau R.

Planta Med. 1997 Aug;63(4):291-5. Review.

PMID:
9270370
19.
20.

Expression profiling of genes involved in paclitaxel biosynthesis for targeted metabolic engineering.

Nims E, Dubois CP, Roberts SC, Walker EL.

Metab Eng. 2006 Sep;8(5):385-94. Epub 2006 May 6.

PMID:
16793302

Supplemental Content

Support Center